Nevertheless, the function and detailed molecular mechanisms of FBXO22 are elusive in osteosarcoma, and further studies are needed to determine whether FBXO22 might be a potent target for therapy in osteosarcoma patients. Here, FBXO22 is linked to osteosarcoma.